Atropos Health

Atropos Health is a healthcare technology company that generates personalized, real-world evidence (RWE) from clinical data, with the stated goal of closing what it describes as "The Evidence Gap" — the finding that only 14% of daily medical decisions are backed by high-quality evidence. The company produces publication-grade observational studies in minutes and at scale, serving both health systems and life sciences organizations. Atropos Health was formally launched in 2020 to scale clinical informatics consults and make RWE accessible across medicine, building on more than a decade of research and technology development originating at Stanford.

The company serves two primary customer segments: health systems (including pharmacy, research informatics, value-based care and quality, and graduate medical education functions) and life sciences organizations (including brand planning, precision medicine AI/ML, HEOR, medical affairs and RWE, research and development, and commercial analytics). Reported outcomes include a 100% success rate in publishing studies in peer-reviewed journals — with over 50 publications in outlets including Cell and NEJM Catalyst — more than 10,000 clinical questions converted into studies, and approximately $100 million saved by clients through expedited analytics, medication cost savings, and care management programs.

Technology Platform

• Alexandria® — described as the world's largest body of medical evidence, designed for clinical decision support and large language model (LLM) training.
• Atropos Evidence™ Agent — an automation solution for evidence generation.
• ChatRWD® — a tool that allows users to query real-world data and generate evidence through a conversational interface.
• Green Button® — a tool enabling clinicians and informaticists to bring aggregate patient data evidence to the point of care, originating from a concept published in 2014.
• Forge® — an additional automation solution within the platform.
• GENEVA OS® — the company's data operating system.
• Atropos Evidence™ Network — a data network supporting evidence generation across multiple sources.
• Data Quality Scoring — a capability for assessing whether data is fit for purpose for a given clinical question.

Platform Capabilities

• Cloud-based, scalable infrastructure for rapid analytics.
• On-demand data access with novel data strategy and fitness scoring to ensure data is appropriate for specific clinical questions.
• Tools enabling users to publish in academic journals, perform regulatory-grade concept queries, and select phenotypes for particular use cases.
• Publication-grade observational studies that can be re-run on a client's own data to support policy changes or precision medicine decisions.
• Conversion of healthcare data — which the company notes is plentiful but siloed — into high-quality evidence without the months-long timelines typical of traditional research settings.

Solutions by Segment

• Health Systems: Pharmacy formulary evaluation, research informatics, value-based care and quality improvement, and graduate medical education (GME) support.
• Life Sciences: Brand planning, precision medicine AI/ML development, health economics and outcomes research (HEOR), medical affairs and RWE generation, research and development support, and commercial analytics.

Company Background and Partnerships

• Founded by Nigam Shah, PhD MBBS (Co-Founder and Chief Data Scientist at Stanford Health Care), Brigham Hyde, PhD (CEO), and Saurabh Gombar, MD PhD (Chief Medical Officer and Adjunct Professor of Medicine at Stanford School of Medicine).
• The company's origins trace to 2011 research using rapid EHR assessment for clinical decision-making, with subsequent development of the Advanced Cohort Engine (ACE) and the world's first informatics consult pilot at Stanford in 2018.
• In 2022, Mayo Clinic Platform partnered with Atropos Health to combine Mayo Clinic data with Atropos' clinical informatics technology to accelerate care insights.
• Customers and advisors include clinical faculty at Stanford University and former chief digital officers at health systems such as Prisma Health.

Mission and Values

• Mission: to accelerate the generation of actionable evidence to improve healthcare outcomes for everyone.
• Vision: to be the leading generative platform and trusted source for novel evidence to inform healthcare decisions.
• Core values include bias to action, intellectual honesty, curiosity, impactful innovation with a focus on equity and representation, and mindful mentorship.

Atropos Health positions its platform as a means of making evidence-based medicine practical and accessible at the point of care and in research settings, reducing the time and cost historically associated with generating credible real-world evidence from clinical data.